Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) announced that its virtual Annual General and Special Meeting of Shareholders will be webcast on June 26, 2024, at 4.30pm Eastern Time.
The webcast can be accessed here.
Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies to treat heart disease.